Parkview Health System, founded in 1878 as Fort Wayne City Hospital is a network of 10 community hospitals and more than 100 clinic locations in northeast Indiana and northwest Ohio. The not-for-profit Parkview Health System is the region's largest employer with more than 13,000.

During the past decade, Parkview Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Parkview Hospital" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Abbott Medical Devices" with 2 trials sponsored, "Astellas Pharma Inc" with 2 trials sponsored, "Indiana University" with 2 trials sponsored and "PhotoThera, Inc" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Parkview Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Beijing Tiantan Hospital" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Parkview Hospital" are "Atherosclerosis" (3 trials), "Acute Ischemic Stroke" (2 trials), "Carotid Artery Disease" (2 trials), "Carotid Stenosis" (2 trials) and "Cerebrovascular Accident" (2 trials). Many other conditions were trialed in "Parkview Hospital" in a lesser frequency.

Most popular intervention types in "Parkview Hospital" are "Drug" (10 trials), "Device" (9 trials), "Other" (5 trials), "Procedure" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "NeuroThera® Laser System" (2 trials), "Placebo" (2 trials), "5-fluorouracil" (1 trials), "AGI-1067" (1 trials) and "Andecaliximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Parkview Hospital" are 24 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Parkview Hospital". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Parkview Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Parkview Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".

Parkview Hospital has several departments that took part in Clinical trials: "Parkview Regional Cancer Center at Parkview Health" - 33 trials, "Parkview Physicians Group - Cardiology" - 2 trials